ToxBench: A Binding Affinity Prediction Benchmark with AB-FEP-Calculated Labels for Human Estrogen Receptor Alpha

Meng Liu, Karl Leswing, Simon K. S. Chu, Farhad Ramezanghorbani, Griffin Young, Gabriel Marques, Prerna Das, Anjali Panikar, Esther Jamir, Mohammed Sulaiman Shamsudeen, K. Shawn Watts, Ananya Sen, Hari Priya Devannagari, Edward B. Miller, Muyun Lihan, Howook Hwang, Janet Paulsen, Xin Yu, Kyle Gion, Timur Rvachov, Emine Kucukbenli, Saee Gopal Paliwal

arXiv:2507.08966·cs.LG·Published 2025-07-11

Protein-ligand binding affinity prediction is essential for drug discovery and toxicity assessment. While machine learning (ML) promises fast and accurate predictions, its progress is constrained by the availability of reliable data. In contrast, physics-based methods such as absolute binding free energy perturbation (AB-FEP) deliver high accuracy but are computationally prohibitive for high-throughput applications. To bridge this gap, we introduce ToxBench, the first large-scale AB-FEP dataset designed for ML development and focused on a single pharmaceutically critical target, Human Estrogen Receptor Alpha (ER$α$). ToxBench contains 8,770 ER$α$-ligand complex structures with binding free energies computed via AB-FEP with a subset validated against experimental affinities at 1.75 kcal/mol RMSE, along with non-overlapping ligand splits to assess model generalizability. Using ToxBench, we further benchmark state-of-the-art ML methods, and notably, our proposed DualBind model, which employs a dual-loss framework to effectively learn the binding energy function. The benchmark results demonstrate the superior performance of DualBind and the potential of ML to approximate AB-FEP at a fraction of the computational cost.

TopicsProperty Prediction & ADMET, Protein & Biomolecules

Tagsdrug-discovery free-energy protein-ligand

arXiv categoriescs.LG, cs.AI, physics.chem-ph, q-bio.BM

arXiv abstract pagePDF